To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
I am now retired from the US pharma industry having spent over 33 years in the Mid-Atlantic corridor in Sales(Hospital mainly), Scientific Relations and Managed Care/LTC. I worked at BMY, Bayer/Miles Labs and SGP/MRK prior to early retirement..
Today I enjoy investing in Bio-Pharmas mostly, because it is what I know best!
I invest mostly in large companies such as BMY, PFE, MRK, GSK, and JNJ (love the divis) but I like the up and coming Bios like CLDX. Cancer and Immunotherapy intrigues me..so I have made that a major consideration since 2008....With BARDA,the GAIN act and QDIP Ive come to appreciate the Antibiotic cos.and have made them a major component of my LT strategy to build wealth while in
Retirement....Ive invested in Trius(TSRX),CBST, CEMP, DRTX, TTPH, CTIX and just added AKAO.....
I manage personal monies and some family members..gratis of course!
Dividend stock ideas & income, Gold, Retirement savings, Stocks - long, Stocks - short, Tech stocks
Currently, there is no company profile for retiredpharma.
Currently, there are no blog details for retiredpharma.
Currently, there are no book details for retiredpharma.
EP,Your article is very BIA...
Double Whammy Is Exactly The Wrong Prescription...
AFREZZA This is what I see ...
MannKind: Weekly Data Updates For Prescriptions
EXEL Long!I would NOT sell ...
ECC - Cometriq Plays Wallflower As Opdivo's Dan...
MAKO Research is now TOAST!...
Ocata Therapeutics: Insider Enrichment, Failed ...
My New Screen Name,I can no...
Tough To Believe But MannKind Is Making Progress
Xignite quote data
© 2015 Seeking Alpha